drugset / Trial / NCT00745186
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics and pharmacodynamic bioequivalence and safety of Hospira Glucagon for Injection and GlucaGen® in healthy volunteers.
Timeline
- Start
- 2007-08
- Primary completion
- 2007-10
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glucagon | Peptide | 0.2 mg | Intramuscular |
| Comparator | Glucagon | Peptide | 1 mg | Intramuscular |
| Subject | Mayne Glucagon | Unknown | 0.2 mg | Intramuscular |
| Subject | Mayne Glucagon | Unknown | 1 mg | Intramuscular |